In the company for which Iworked prior to founding Neuralytix, the IT staff at the company told me that I had more email folders that anyone else they had ever experienced.
Once more: I find it hard to understand how someone who worked as head of Research and Development at Pfizer could possibly deny this basic, universally recognised problem of poor external validity in clinical trials.